由EGFR V843I种系突变引起的家族性肺腺癌。 - Suppr

Familial lung adenocarcinoma caused by the EGFR V843I germ-line mutation.

作者信息

Ohtsuka Kouki, Ohnishi Hiroaki, Kurai Daisuke, Matsushima Satsuki, Morishita Yukio, Shinonaga Mayumi, Goto Hajime, Watanabe Takashi

机构信息

Kyorin University School of Medicine, Tokyo, Japan.

出版信息

J Clin Oncol. 2011 Mar 10;29(8):e191-2. doi: 10.1200/JCO.2010.31.4492. Epub 2010 Dec 20.

DOI:10.1200/JCO.2010.31.4492

PMID:21172876

Abstract

摘要

相似文献

Familial lung adenocarcinoma caused by the EGFR V843I germ-line mutation.

J Clin Oncol. 2011 Mar 10;29(8):e191-2. doi: 10.1200/JCO.2010.31.4492. Epub 2010 Dec 20.

Novel germline mutation: EGFR V843I in patient with multiple lung adenocarcinomas and family members with lung cancer.

Ann Thorac Surg. 2008 Apr;85(4):1430-2. doi: 10.1016/j.athoracsur.2007.10.012.

Inherited susceptibility to lung cancer may be associated with the T790M drug resistance mutation in EGFR.

Nat Genet. 2005 Dec;37(12):1315-6. doi: 10.1038/ng1671. Epub 2005 Oct 30.

A dramatic lung cancer course in a patient with a rare EGFR germline mutation exon 21 V843I: Is EGFR TKI resistance predictable?

Lung Cancer. 2013 Apr;80(1):81-4. doi: 10.1016/j.lungcan.2012.11.013. Epub 2013 Feb 4.

Activating germline R776H mutation in the epidermal growth factor receptor associated with lung cancer with squamous differentiation.

J Clin Oncol. 2013 Apr 1;31(10):e161-4. doi: 10.1200/JCO.2012.42.1586. Epub 2013 Jan 28.

Modern treatment of lung cancer: case 1. Amplification and mutation of the epidermal growth factor receptor in metastatic lung cancer with remission from gefitinib.

J Clin Oncol. 2005 Oct 20;23(30):7736-8. doi: 10.1200/JCO.2005.02.4760.

EGFR and K-ras mutations along the spectrum of pulmonary epithelial tumors of the lung and elaboration of a combined clinicopathologic and molecular scoring system to predict clinical responsiveness to EGFR inhibitors.

Am J Clin Pathol. 2009 Apr;131(4):478-89. doi: 10.1309/AJCPH0TRMPXVZW2F.

Cytomorphological correlates of epidermal growth factor receptor mutations in lung carcinoma.

Diagn Cytopathol. 2007 May;35(5):257-62. doi: 10.1002/dc.20617.

EGFR mutations and the terminal respiratory unit.

Cancer Metastasis Rev. 2010 Mar;29(1):23-36. doi: 10.1007/s10555-010-9205-8.

[Should we always use EGFR mutation analysis prior to palliative firstline therapy of metastatic adenocarcinoma of the lung? Pro].

Dtsch Med Wochenschr. 2012 Mar;137(12):592. doi: 10.1055/s-0031-1298873. Epub 2012 Mar 13.

引用本文的文献

The pathogenic germline ETV4 P433L mutation identified in multiple primary lung cancer affect tumor stem-like property by Wnt/β-catenin pathway.

Cell Death Dis. 2024 Oct 10;15(10):738. doi: 10.1038/s41419-024-07129-z.

Benefits of osimertinib treat a lung adenocarcinoma patient with germline EGFR T790M, somatic EGFR 19-Del, TP53 and PIK3CA mutations.

Hered Cancer Clin Pract. 2024 Aug 19;22(1):13. doi: 10.1186/s13053-024-00286-4.

Lung cancer in patients who have never smoked - an emerging disease.

Nat Rev Clin Oncol. 2024 Feb;21(2):121-146. doi: 10.1038/s41571-023-00844-0. Epub 2024 Jan 9.

Germline EGFR mutations in lung cancer (Review).

Oncol Lett. 2023 May 16;26(1):282. doi: 10.3892/ol.2023.13868. eCollection 2023 Jul.

Two germline mutations can serve as genetic susceptibility screening makers for a lung adenocarcinoma family.

J Cancer Res Clin Oncol. 2023 Aug;149(9):6541-6548. doi: 10.1007/s00432-023-04616-2. Epub 2023 Feb 13.

Cancer Predisposition Genes in Adolescents and Young Adults (AYAs): a Review Paper from the Italian AYA Working Group.

Curr Oncol Rep. 2022 Jul;24(7):843-860. doi: 10.1007/s11912-022-01213-3. Epub 2022 Mar 23.

Pedigree analysis of the p.V1010M germline mutation in a family with a family history of non-small-cell lung cancer.

Ann Transl Med. 2022 Feb;10(3):154. doi: 10.21037/atm-21-6925.

Genomic Profiling of Lung Adenocarcinoma in Never-Smokers.

J Clin Oncol. 2021 Nov 20;39(33):3747-3758. doi: 10.1200/JCO.21.01691. Epub 2021 Sep 30.

Lung cancer screening: who pays? who receives?-the Chinese perspective.

Transl Lung Cancer Res. 2021 May;10(5):2389-2394. doi: 10.21037/tlcr.2020.03.16.

Epidermal Growth Factor Receptor Expression and Resistance Patterns to Targeted Therapy in Non-Small Cell Lung Cancer: A Review.

Cells. 2021 May 14;10(5):1206. doi: 10.3390/cells10051206.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Familial lung adenocarcinoma caused by the EGFR V843I germ-line mutation.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献